Exane Derivatives’s Fiat Chrysler Automobiles N.V. FCAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-2,265
Closed -$163K 647
2016
Q1
$163K Buy
2,265
+300
+15% +$20K 0.02% 208
2015
Q4
$226K Buy
1,965
+1,900
+2,923% +$236K 0.03% 155
2015
Q3
$7.7K Sell
65
-6,100
-99% -$783K ﹤0.01% 367
2015
Q2
$788K Buy
6,165
+1,100
+22% +$148K 0.08% 109
2015
Q1
$696K Buy
+5,065
New +$634K 0.08% 116

Other funds holding FCAM

Exane Derivatives's FCAM Position: Q2 2016 in Review

Exane Derivatives sold out of Fiat Chrysler Automobiles N.V. (FCAM) in Q2 2016, closing a stake of 2,265 shares — an estimated $163K sold.

Exane Derivatives first reported a position in FCAM in Q1 2015 and held it in 5 quarters. The position peaked at $788K in Q2 2015. 28 funds tracked by Wall St. Rank hold FCAM as of Q2 2016.

  • Exane Derivatives reported no remaining Fiat Chrysler Automobiles N.V. position as of Q2 2016 after selling out during the quarter.
  • Exane Derivatives sold 2,265 Fiat Chrysler Automobiles N.V. shares in Q2 2016, an estimated $163K.
  • Exane Derivatives first reported a position in Fiat Chrysler Automobiles N.V. in Q1 2015 and held it in 5 quarters.
  • Exane Derivatives's Fiat Chrysler Automobiles N.V. position peaked at $788K in Q2 2015.
  • 28 funds tracked by Wall St. Rank held Fiat Chrysler Automobiles N.V. as of Q2 2016.

Based on Exane Derivatives's 13F filing for Q2 2016, filed 3 Aug 2016.